Cargando…

CYTOPLASMIC-MEMBRANE EGFR PREDICTS EXPANDED RAS MUTATION STATUS IN COLORECTAL CARCINOMAS?

BACKGROUND: Inhibitors of the epidermal growth factor (EGFR) represent an effective therapeutic option for patients with metastatic colorectal carcinoma, free of activating mutations in KRAS and NRAS. However, the research of mutations is of high cost and scarcely accessible. The expression of the E...

Descripción completa

Detalles Bibliográficos
Autores principales:	PINTO, Thiago David Alves, ALVES, Thaís David das Neves, PINTO, Sebastião Alves, OLIVEIRA, Enio Chaves
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Colégio Brasileiro de Cirurgia Digestiva 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8195465/ https://www.ncbi.nlm.nih.gov/pubmed/34133521 http://dx.doi.org/10.1590/0102-672020210001e1574

Ejemplares similares

A two-component protein condensate of the EGFR cytoplasmic tail and Grb2 regulates Ras activation by SOS at the membrane
por: Lin, Chun-Wei, et al.
Publicado: (2022)

Liquid Biopsies in Progressing Metastatic Colorectal Cancer- Application and their Therapeutic Implications According to the RAS Status
por: Pereira, José, et al.
Publicado: (2020)

Acquired RAS or EGFR mutations and duration of response to EGFR blockade in colorectal cancer
por: Van Emburgh, Beth O., et al.
Publicado: (2016)

Case for diagnosis()
por: Oliveira, Lorena Cassia de Carvalho, et al.
Publicado: (2014)

Uncoupling of EGFR–RAS signaling and nuclear localization of YBX1 in colorectal cancer
por: Roßner, F, et al.
Publicado: (2016)

Acetate-induced apoptosis in colorectal carcinoma cells involves lysosomal membrane permeabilization and cathepsin D release
por: Marques, C, et al.
Publicado: (2013)

EGFR-RAS-MAPK signaling is confined to the plasma membrane and associated endorecycling protrusions
por: Surve, Sachin, et al.
Publicado: (2021)

Phosphorylated EGFR Dimers Are Not Sufficient to Activate Ras
por: Liang, Samantha I., et al.
Publicado: (2018)

EGFR/Ras-induced CCL20 production modulates the tumour microenvironment
por: Hippe, Andreas, et al.
Publicado: (2020)

Correction to: EGFR/Ras-induced CCL20 production modulates the tumour microenvironment
por: Hippe, Andreas, et al.
Publicado: (2021)

Transient Disappearance of RAS Mutant Clones in Plasma: A Counterintuitive Clinical Use of EGFR Inhibitors in RAS Mutant Metastatic Colorectal Cancer
por: Raimondi, Cristina, et al.
Publicado: (2019)

Undetectable RAS-Mutant Clones in Plasma: Possible Implication for Anti-EGFR Therapy and Prognosis in Patients With RAS-Mutant Metastatic Colorectal Cancer
por: Bouchahda, Mohamed, et al.
Publicado: (2020)

Herpetic Esophagitis in Immunocompetent Medical Student
por: Marinho, Andréia Vidica, et al.
Publicado: (2014)

Editorial: The expanding clinical and genetic basis of adult inherited neurometabolic disorders
por: Pinto, Wladimir Bocca Vieira de Rezende, et al.
Publicado: (2023)

ELOVL5 Participates in Embryonic Lipid Determination of Cellular Membranes and Cytoplasmic Droplets
por: Lanzarini, Franciele, et al.
Publicado: (2021)

EGFR and K-ras gene mutation status in squamous cell anal carcinoma: a role for concurrent radiation and EGFR inhibitors?
por: Paliga, A, et al.
Publicado: (2012)

Panitumumab in Metastatic Colorectal Cancer: The Importance of Tumour RAS Status
por: Peeters, Marc, et al.
Publicado: (2015)

Kinase-mediated RAS signaling via membraneless cytoplasmic protein granules
por: Tulpule, Asmin, et al.
Publicado: (2021)

Dynamics of RAS/BRAF Mutations in cfDNA from Metastatic Colorectal Carcinoma Patients Treated with Polychemotherapy and Anti-EGFR Monoclonal Antibodies
por: Rachiglio, Anna Maria, et al.
Publicado: (2022)

Comparison of EGFR and K-RAS gene status between primary tumours and corresponding metastases in NSCLC
por: Kalikaki, A, et al.
Publicado: (2008)

Cutting the Brakes on Ras—Cytoplasmic GAPs as Targets of Inactivation in Cancer
por: Bellazzo, Arianna, et al.
Publicado: (2020)

Targeting BRAF and RAS in Colorectal Cancer
por: Bellio, Helene, et al.
Publicado: (2021)

Characterization of membranous and cytoplasmic EGFR expression in human normal renal cortex and renal cell carcinoma
por: Pu, Yeong-Shiau, et al.
Publicado: (2009)

Protein biomarkers predictive for response to anti-EGFR treatment in RAS wild-type metastatic colorectal carcinoma
por: Lièvre, Astrid, et al.
Publicado: (2017)

Evaluating the Optimal Sequence of Treatment With EGFR Inhibitors and Bevacizumab in RAS Wild-Type Metastatic Colorectal Cancer
por: Martins, Diana, et al.
Publicado: (2022)

Current Approaches in NSCLC Targeting K-RAS and EGFR
por: Aran, Veronica, et al.
Publicado: (2019)

Expression of pEGFR and pAKT as response-predictive biomarkers for RAS wild-type patients to anti-EGFR monoclonal antibodies in metastatic colorectal cancers
por: Harlé, A, et al.
Publicado: (2015)

Concordance of blood- and tumor-based detection of RAS mutations to guide anti-EGFR therapy in metastatic colorectal cancer
por: Grasselli, J, et al.
Publicado: (2017)

Correction: Protein biomarkers predictive for response to anti-EGFR treatment in RAS wild-type metastatic colorectal carcinoma
por: Lièvre, Astrid, et al.
Publicado: (2018)

Multivariate Risk Analysis of RAS, BRAF and EGFR Mutations Allelic Frequency and Coexistence as Colorectal Cancer Predictive Biomarkers
por: Ionescu, Adriana, et al.
Publicado: (2022)

RAS-expanded Mutations and HER2 Expression in Metastatic Colorectal Cancer: A New Step of Precision Medicine
por: Valentini, Anna M., et al.
Publicado: (2018)

RAS Mutational Status Detection in Tissue, Plasma, and Stool Samples for Colorectal Cancer
por: Zhu, Liuying, et al.
Publicado: (2020)

HER-2 and EGFR mRNA Expression and Its Relationship with Versican in Malignant Matrix-Producing Tumors of the Canine Mammary Gland
por: Damasceno, Karine Araújo, et al.
Publicado: (2016)

Mechanisms of Ras Membrane Organization and Signaling: Ras Rocks Again
por: Abankwa, Daniel, et al.
Publicado: (2020)

Validation of a machine learning approach to estimate expanded disability status scale scores for multiple sclerosis
por: Alves, Pedro, et al.
Publicado: (2022)

Effect of RAS status on anti-EGFR monoclonal antibodies + 5-FU infusion-based chemotherapy in first-line treatment of metastatic colorectal cancer: A meta-analysis
por: Zhou, Mingyi, et al.
Publicado: (2016)

EMT-Induced Stemness and Tumorigenicity Are Fueled by the EGFR/Ras Pathway
por: Voon, Dominic Chih-Cheng, et al.
Publicado: (2013)

Esophageal schwannoma: Case report and epidemiological, clinical, surgical and immunopathological analysis()
por: Souza, Luiz Carlos de Araújo, et al.
Publicado: (2019)

Clinical findings in congenital infection by Zika virus: a retrospective study in a reference hospital in Central-West Brazil
por: de Paula Guimarães, Cláudia, et al.
Publicado: (2019)

Genetic evidence for a species complex within the piranha Serrasalmus maculatus (Characiformes, Serrasalmidae) from three Neotropical river basins based on mitochondrial DNA sequences
por: Bignotto, Thaís Souto, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_fiam02124f5n4vlcbb61bjsiff